Key Details
Price
$73.79Last Dividend
$0.08Annual ROE
8.33%Beta
1.03Events Calendar
Next earnings date:
Jan 31, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Aug 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 08, 2024Next split:
N/ARecent split:
Nov 30, 2022Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Guangzhou, Dec. 19, 2024 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (referred to as “the Company” or “YSXT”), a company based in the Cayman Islands that offers business solutions primarily for insurance firms and brokerages in China, has successfully completed its initial public offering (the “Offering”). They sold 1,250,000 Class A ordinary shares at a price of $4.00 each, raising around $5,000,000 before expenses. The Offering was finalized on December 19, 2024, and the shares began trading on the Nasdaq Capital Market on December 18, 2024, under the ticker “YSXT.”
On December 18, 2024, in St. Paul, Minnesota, ScaleReady, along with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, announced that Moonlight Bio has received a G-Rex® Grant.
Guangzhou, Dec. 17, 2024 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (referred to as “the Company” or “YSXT”), a company based in the Cayman Islands that offers business solutions primarily for insurance firms and brokerages in China, has announced the pricing of its initial public offering (the “Offering”). They will sell 1,250,000 Class A ordinary shares at a price of $4.00 each, aiming to raise about $5,000,000 before expenses. The shares have been approved for listing on the Nasdaq Capital Market and are set to begin trading on December 18, 2024, under the ticker symbol “YSXT.”
TECH's Asuragen brand has introduced a very sensitive test for monitoring ESR1 mutations.
Bio-Techne's success in four areas of growth and its expansion through buying other companies look promising.
TECH is experiencing ongoing growth in its Diagnostics and Spatial Biology division.
On Wednesday, Bio-Techne exceeded profit expectations for the first quarter, thanks to growth in its diagnostics and spatial biology areas. This news caused the biotech company's shares to rise by 4.59% in premarket trading.
On October 29, 2024, in St. Paul, Minnesota, ScaleReady, together with Wilson Wolf Manufacturing and Bio-Techne Corporation, announced that Luminary Therapeutics has received a G-Rex® Grant worth $300,000.
A new training program is being introduced to address the increasing need for Hyundai and Genesis automotive technicians across the country. This initiative aims to prepare more skilled workers for these roles. It responds to the rising demand in the automotive industry.
SCOTTSDALE, Ariz., Oct. 10, 2024 /PRNewswire/ -- Cyber Enviro-Tech Inc. (CETI) (OTCQB: CETI) is excited to share that it has formed a partnership with its subsidiary, CETI Axenic (CAX), which is owned by its shareholders, to explore possibilities in the commercial laundry sector.
FAQ
- What is the primary business of Bio-Techne?
- What is the ticker symbol for Bio-Techne?
- Does Bio-Techne pay dividends?
- What sector is Bio-Techne in?
- What industry is Bio-Techne in?
- What country is Bio-Techne based in?
- When did Bio-Techne go public?
- Is Bio-Techne in the S&P 500?
- Is Bio-Techne in the NASDAQ 100?
- Is Bio-Techne in the Dow Jones?
- When was Bio-Techne's last earnings report?
- When does Bio-Techne report earnings?
- Should I buy Bio-Techne stock now?